The fact that CD8+ T cells outnumber CD4+ T cells in MS lesions was first observed in the 80s, in particular in the parenchyma, and was regardless of differing clinical parameters, such as disease duration, disease evolution, and therapy (19). This evidence concerns the gene CD4 and myeloid sarcoma.